Kinase drug discovery remains a vital area in developing targeted therapies for diseases like cancer, inflammatory disorders, and more. Despite significant advances, challenges persist, including overcoming drug resistance, improving selectivity to minimize off-target effects, identifying novel kinase targets, and tailoring treatments to individual patients through personalized medicine. Additionally, expanding the use of kinase inhibitors to treat non-cancerous diseases opens new avenues for research and development. Addressing these unmet needs requires innovative approaches in drug design, a deeper understanding of disease mechanisms, and the integration of new technologies to refine clinical strategies, promising a future of more effective and precise treatments in kinase-targeted therapy.
